Innovative Therapies and Clinical Studies for Screenable Disorders (R03)

The summary for the Innovative Therapies and Clinical Studies for Screenable Disorders (R03) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Innovative Therapies and Clinical Studies for Screenable Disorders (R03): The National Institute of Child Health and Human Development (NICHD), the National Institute on Deafness and Other Communication Disorders (NIDCD), and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invite applications for research relevant to the basic understanding and development of therapeutic interventions for currently screened conditions and high priority genetic conditions for which screening could be possible in the near future. In this Funding Opportunity Announcement (FOA), a high priority condition is a condition for which the development of an efficacious therapy would make the condition amenable to newborn screening. -Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the numbers, quality, duration, and costs of the applications received. -This FOA will use the NIH Small Research Grant (R03) award mechanism and runs in parallel with two FOAs of identical scientific scope, PAR-06-342 and PAR-06-060, that utilize the Exploratory/Developmental Research Grant (R21) and the traditional Research Project Grant (R01) award mechanisms, respectively. -The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources. The R03 is not renewable. - Budget and Project Period: Budgets for direct costs up to $50,000 per year and a project duration of up to two years may be requested for a maximum of $100,000 direct costs over a two-year project period. - Eligible Organizations: For-profit and non-profit organizations; public or private institutions, such as universities, colleges, hospitals, and laboratories; units of State and local governments; eligible agencies of the Federal government ; domestic and foreign institutions/organizations; faith-based or community-based organizations; units of State Tribal government; and units of Local Tribal government. - Eligible Project Directors/Principal Investigators (PDs/PIs): Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their institution to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. -Applicants may submit more than one application, provided each application is scientifically distinct.
Federal Grant Title: Innovative Therapies and Clinical Studies for Screenable Disorders (R03)
Federal Agency Name: National Institutes of Health
Grant Categories: Health Income Security and Social Services
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-06-341
Type of Funding: Grant
CFDA Numbers: 93.17393.847
CFDA Descriptions: Research Related to Deafness and Communication Disorders 93.847 Diabetes, Endocrinology and Metabolism Research
Current Application Deadline: No deadline provided
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Posted Date: Apr 10, 2006
Creation Date: Oct 05, 2007
Archive Date: Dec 05, 2008
Total Program Funding:
Maximum Federal Grant Award: $50,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: 93.865 -- Child Health and Human Development Extramural Research
Applicants Eligible for this Grant
Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification) Native American tribal governments (Federally recognized) Private institutions of higher education Public housing authorities/Indian housing authorities Small businesses Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education State governments City or township governments County governments Public and State controlled institutions of higher education
Additional Information on Eligibility
Foreign institutions are eligible to apply. Eligible agencies of the Federal Government are eligible to apply. Faith-based or community-based organizations
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster